These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 8353896)
1. Do antisense approaches to the problem of restenosis make sense? Epstein SE; Speir E; Finkel T Circulation; 1993 Sep; 88(3):1351-3. PubMed ID: 8353896 [No Abstract] [Full Text] [Related]
2. Antisense therapy for angioplasty restenosis. Some critical considerations. Bennett MR; Schwartz SM Circulation; 1995 Oct; 92(7):1981-93. PubMed ID: 7671381 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells. Shi Y; Hutchinson HG; Hall DJ; Zalewski A Circulation; 1993 Sep; 88(3):1190-5. PubMed ID: 8353880 [TBL] [Abstract][Full Text] [Related]
4. Antiangiogenesis: a suitable preventive treatment of restenosis. Beranek JT Cathet Cardiovasc Diagn; 1993 Feb; 28(2):184-6. PubMed ID: 7680604 [No Abstract] [Full Text] [Related]
5. Inhibition of smooth muscle cell proliferation by an antisense oligodeoxynucleotide targeting the messenger RNA encoding proliferating cell nuclear antigen. Speir E; Epstein SE Circulation; 1992 Aug; 86(2):538-47. PubMed ID: 1353419 [TBL] [Abstract][Full Text] [Related]
6. Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury. Shi Y; Fard A; Galeo A; Hutchinson HG; Vermani P; Dodge GR; Hall DJ; Shaheen F; Zalewski A Circulation; 1994 Aug; 90(2):944-51. PubMed ID: 8044966 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. Bennett MR; Anglin S; McEwan JR; Jagoe R; Newby AC; Evan GI J Clin Invest; 1994 Feb; 93(2):820-8. PubMed ID: 8113414 [TBL] [Abstract][Full Text] [Related]
8. Antisense oligonucleotides to the p65 subunit of NF-kB inhibit human vascular smooth muscle cell adherence and proliferation and prevent neointima formation in rat carotid arteries. Autieri MV; Yue TL; Ferstein GZ; Ohlstein E Biochem Biophys Res Commun; 1995 Aug; 213(3):827-36. PubMed ID: 7654244 [TBL] [Abstract][Full Text] [Related]
9. Sequence-specific antiproliferative effects of antisense and end-capping-modified antisense oligodeoxynucleotides targeted against the 5'-terminus of basic-fibroblast-growth-factor mRNA in coronary smooth muscle cells. Schmidt A; Sindermann J; Peyman A; Uhlmann E; Will DW; Müller JG; Breithardt G; Buddecke E Eur J Biochem; 1997 Sep; 248(2):543-9. PubMed ID: 9346314 [TBL] [Abstract][Full Text] [Related]
12. Processing of chimeric antisense oligonucleotides by human vascular smooth muscle cells and human atherosclerotic plaque. Implications for antisense therapy of restenosis after angioplasty. Pickering JG; Isner JM; Ford CM; Weir L; Lazarovits A; Rocnik EF; Chow LH Circulation; 1996 Feb; 93(4):772-80. PubMed ID: 8641007 [TBL] [Abstract][Full Text] [Related]
13. [Antisense oligonucleotides inhibit c-myc and PCNA expression in the vascular smooth muscle cells]. Bian J; Zhang B; Chen S Zhonghua Yi Xue Za Zhi; 1999 Jan; 79(1):10-4. PubMed ID: 11600998 [TBL] [Abstract][Full Text] [Related]
14. Uptake kinetics of 99mTc-MAG3-antisense oligonucleotide to PCNA and effect on gene expression in vascular smooth muscle cells. Zhang YR; Zhang YX; Cao W; Lan XL J Nucl Med; 2005 Jun; 46(6):1052-8. PubMed ID: 15937319 [TBL] [Abstract][Full Text] [Related]
15. Regulation of monocyte chemoattractant protein-1 by the oxidized lipid, 13-hydroperoxyoctadecadienoic acid, in vascular smooth muscle cells via nuclear factor-kappa B (NF-kappa B). Dwarakanath RS; Sahar S; Reddy MA; Castanotto D; Rossi JJ; Natarajan R J Mol Cell Cardiol; 2004 Apr; 36(4):585-95. PubMed ID: 15081318 [TBL] [Abstract][Full Text] [Related]
16. Abnormal growth regulation of vascular smooth muscle cells by heparin in patients with restenosis. Chan P; Patel M; Betteridge L; Munro E; Schachter M; Wolfe J; Sever P Lancet; 1993 Feb; 341(8841):341-2. PubMed ID: 8094116 [TBL] [Abstract][Full Text] [Related]
17. [Suppression of vascular smooth muscle cell proliferation by an antisense oligonucleotide against PDGF receptor]. Sugiki H Hokkaido Igaku Zasshi; 1995 May; 70(3):485-95. PubMed ID: 7590599 [TBL] [Abstract][Full Text] [Related]
18. Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation. Geraldes P; Sirois MG; Tanguay JF Circ Res; 2003 Sep; 93(5):399-405. PubMed ID: 12893737 [TBL] [Abstract][Full Text] [Related]
19. Dopamine as a novel anti-migration factor of vascular smooth muscle cells through D1A and D1B receptors. Yasunari K; Maeda K; Nakamura M; Yoshikawa J J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S33-8. PubMed ID: 12688394 [TBL] [Abstract][Full Text] [Related]
20. Gene therapy for restenosis. Smith RC; Walsh K Curr Cardiol Rep; 2000 Jan; 2(1):13-23. PubMed ID: 10980867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]